Get the Stockscreener App
9.65
3.26%
0.30
Evolent Health Inc stock is traded at $9.65, with a volume of 644.71K.
It is up +3.26% in the last 24 hours and down -9.85% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
See More
Previous Close:
$9.35
Open:
$9.45
24h Volume:
644.71K
Relative Volume:
0.26
Market Cap:
$1.13B
Revenue:
$2.35B
Net Income/Loss:
$-74.42M
P/E Ratio:
-10.27
EPS:
-0.94
Net Cash Flow:
$150.93M
1W Performance:
+1.31%
1M Performance:
-9.85%
6M Performance:
-4.40%
1Y Performance:
-56.49%
1-Day Range:
$9.38
$9.74
1-Week Range:
$9.34
$10.35
52-Week Range:
$7.06
$33.48
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
9.65 | 1.20B | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
289.81 | 46.74B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
63.41 | 11.23B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
60.89 | 11.43B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.69 | 8.38B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.27 | 6.39B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
What drives Evolent Health Inc. stock priceAccelerated investment success - PrintWeekIndia
What makes Evolent Health Inc. stock attractive to long term investorsMarket-crushing profits - jammulinksnews.com
How Evolent Health Inc. stock reacts to Fed policy changesJaw-dropping returns - jammulinksnews.com
What analysts say about Evolent Health Inc. stockHigh-margin investment plays - Autocar Professional
Will Evolent Health Inc. stock split in the near futureDouble-digit growth - jammulinksnews.com
The Analyst Verdict: Evolent Health In The Eyes Of 5 Experts - 富途牛牛
Elevance Health, EchoStar, Icahn Enterprises, Evolent Health, and The Trade Desk Shares Are Soaring, What You Need To Know - TradingView
Is Evolent Health Inc. a good long term investmentExceptional market positioning - jammulinksnews.com
Evolent Health Inc. Stock Analysis and ForecastFree Investment Timing Strategies - jammulinksnews.com
Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $16 - 富途牛牛
Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know - Yahoo Finance
Truist Securities Raises Price Target for Evolent Health (EVH) | - GuruFocus
Evolent Health: Truist Securities Maintains Buy, Raises PT to $16 from $14. - AInvest
Evolent Health Insiders Added US$1.35m Of Stock To Their Holdings - 富途牛牛
Evolent Health Announces Q2 Earnings Date and Major Growth Conference Appearance - Stock Titan
Evolent Health, Inc. (NYSE:EVH) Stock Catapults 35% Though Its Price And Business Still Lag The Industry - simplywall.st
Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025 - Yahoo Finance
EVH Press Release: Evolent To Release Second Quarter 2025 Financi... - 富途牛牛
Evolent Health taps David Lim as chief clinical officer - MSN
U.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To Know - TradingView
BPAS - FinancialContent
Evolent adds Dr. David Lim as chief clinical officer, John Way as CFO By Investing.com - Investing.com South Africa
Evolent Health Appoints Dr. David Lim as Chief Clinical Officer; John Way as CFO, Performance Suite - citybiz
Evolent adds Dr. David Lim as chief clinical officer, John Way as CFO - Investing.com
Former OptumHealth CFO Joins Evolent as Healthcare Giant Expands Specialty Care Leadership - Stock Titan
Evolent Health stock rating reaffirmed at Buy by Truist on managed care trends - Investing.com Canada
The Top 5 Analyst Questions From Evolent Health’s Q1 Earnings Call - Yahoo Finance
SUN extends revolver to 2030, upsizes to $2.46B for Parkland deal | EVH SEC FilingForm 4 - Stock Titan
JMP Maintains Price Target and Market Outperform Rating on Evolent Health (EVH) - Insider Monkey
Evolent Health, Inc.(NYSE: EVH) added to Russell Small Cap Comp Value Index - MarketScreener
3 Reasons to Avoid EVH and 1 Stock to Buy Instead - Yahoo Finance
EVH Stock Up 30% after 5-Day Win Streak - Trefis
Evolent Health (EVH) Announces Positive Developments Amid Market Concerns | EVH Stock News - GuruFocus
Evolent Health (EVH) Rating Reaffirmed by JMP Securities | EVH S - GuruFocus
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.19%
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):